Literature DB >> 29140689

Tissue Inhibitor of Metalloprotease-2 (TIMP-2): Bioprocess Development, Physicochemical, Biochemical, and Biological Characterization of Highly Expressed Recombinant Protein.

Anandã Chowdhury1, Robert Brinson2, Beiyang Wei1, William G Stetler-Stevenson1.   

Abstract

Tissue inhibitor of metalloprotease-2 (TIMP-2) is a secreted 21 kDa multifunctional protein first described as an endogenous inhibitor of matrix metalloproteinases (MMPs) that prevents breakdown of the extracellular matrix often observed in chronic diseases. TIMP-2 diminishes the level of growth factor-mediated cell proliferation in vitro, as well as neoangiogenesis and tumor growth in vivo independent of its MMP inhibitory activity. These physiological properties make TIMP-2 an excellent candidate for further preclinical development as a biologic therapy of cancer. Here we present a straightforward bioprocessing methodology that yields >35 mg/L recombinant human TIMP-2 6XHis-tagged protein (rhTIMP-2) from suspension cultures of HEK-293-F cells. Enhanced rhTIMP-2-6XHis yields were achieved by optimization of both TIMP-2 cDNA codon sequence and cell culture conditions. Using a two-step chromatographic process, we achieved >95% purity with minimal processing losses. Purified rhTIMP-2-6XHis was free of mouse antigen contamination. Circular dichroism spectroscopy indicated a well-folded rhTIMP-2-6XHis that is highly stable and refractory to pH changes. Two-dimensional heteronuclear single-quantum coherence nuclear magnetic resonance of full length rhTIMP-2-6XHis also indicated a monodisperse, well-folded protein preparation. Purified rhTIMP-2-6XHis inhibited MMP-2 enzymatic activity in a dose-dependent fashion with an IC50 of ∼1.4 nM. Pretreatment of A549 lung cancer and JygMC(A) triple-negative breast cancer cells with rhTIMP-2-6XHis in low-nanomolar amounts inhibited EGF-induced proliferation to basal (unstimulated) levels. This study therefore not only offers a robust bioprocess methodology for rhTIMP-2 production but also characterizes critical physicochemical and biological attributes that are useful for monitoring quality control of the production process.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29140689      PMCID: PMC6322544          DOI: 10.1021/acs.biochem.7b00700

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  A high-affinity carbohydrate-containing inhibitor of matrix metalloproteinases.

Authors:  Vito Calderone; Marco Fragai; Claudio Luchinat; Cristina Nativi; Barbara Richichi; Stefano Roelens
Journal:  ChemMedChem       Date:  2006-06       Impact factor: 3.466

2.  Using circular dichroism spectra to estimate protein secondary structure.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

4.  Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds.

Authors:  Paul Schanda; Bernhard Brutscher
Journal:  J Am Chem Soc       Date:  2005-06-08       Impact factor: 15.419

5.  Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Authors:  Laura P Stabile; Jennifer S Lyker; Christopher T Gubish; Weiping Zhang; Jennifer R Grandis; Jill M Siegfried
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

6.  Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions.

Authors:  P T Wingfield; J K Sax; S J Stahl; J Kaufman; I Palmer; V Chung; M L Corcoran; D E Kleiner; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

7.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition.

Authors:  S E Hoegy; H R Oh; M L Corcoran; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  2000-10-19       Impact factor: 5.157

Review 8.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

Review 9.  Strategies for MMP inhibition in cancer: innovations for the post-trial era.

Authors:  Christopher Mark Overall; Carlos López-Otín
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 10.  The angiogenic switch in solid tumors: clinical implications.

Authors:  Francesca Tosetti; Roberto Benelli; Adriana Albini
Journal:  Suppl Tumori       Date:  2002 Nov-Dec
View more
  6 in total

Review 1.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

2.  Macromolecule-Network Electrostatics Controlling Delivery of the Biotherapeutic Cell Modulator TIMP-2.

Authors:  Yuji Yamada; Ananda Chowdhury; Joel P Schneider; William G Stetler-Stevenson
Journal:  Biomacromolecules       Date:  2018-03-19       Impact factor: 6.988

3.  TIMP-2 suppresses tumor growth and metastasis in murine model of triple-negative breast cancer.

Authors:  David Peeney; Sandra M Jensen; Nadia P Castro; Sarvesh Kumar; Silvia Noonan; Chenchen Handler; Alex Kuznetsov; Joanna Shih; Andy D Tran; David S Salomon; William G Stetler-Stevenson
Journal:  Carcinogenesis       Date:  2020-05-14       Impact factor: 4.944

4.  High-Affinity Binding of LDL Receptor-Related Protein 1 to Matrix Metalloprotease 1 Requires Protease:Inhibitor Complex Formation.

Authors:  Allison L Arai; Mary Migliorini; Dianaly T Au; Elizabeth Hahn-Dantona; David Peeney; William G Stetler-Stevenson; Selen C Muratoglu; Dudley K Strickland
Journal:  Biochemistry       Date:  2020-08-06       Impact factor: 3.162

Review 5.  Targeting extracellular Hsp90: A unique frontier against cancer.

Authors:  Rebecca A Sager; Farzana Khan; Lorenzo Toneatto; SarahBeth D Votra; Sarah J Backe; Mark R Woodford; Mehdi Mollapour; Dimitra Bourboulia
Journal:  Front Mol Biosci       Date:  2022-08-17

6.  TIMP-2 gene rs4789936 polymorphism is associated with increased risk of breast cancer and poor prognosis in Southern Chinese women.

Authors:  Gaoming Liu; Jiayou Luo
Journal:  Aging (Albany NY)       Date:  2020-10-07       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.